Rainbow Childrens Medicare Ltd rainbow childrens medicare has moved to expand its footprint in Andhra Pradesh by acquiring a controlling 64% stake in Super Prime Medical Care LLP for ₹19.84 Cr. The deal secures a running 70-bed children's hospital in Nellore, enhancing the company's specialized pediatric care network and reinforcing its hub-and-spoke model across the state. This strategic addition is expected to improve patient accessibility and strengthen referral pathways in the region, contributing to long-term shareholder value.

The transaction was disclosed pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Schedule III and the SEBI Master Circular dated January 30, 2026. Rainbow Childrens Medicare executed the Partnership Interest and Contribution Transfer Agreement (PICTA) with the existing partners of Super Prime Medical Care LLP. Upon completion, the LLP will become a subsidiary of the listed entity. The acquisition is not classified as a related party transaction, and no promoter or group company holds an interest in the target entity.

Super Prime Medical Care LLP, incorporated on February 8, 2023, operates a hospital providing allied healthcare services in Nellore. The target entity reported an unaudited provisional turnover of ₹9.44 Crore for FY26, a significant increase from ₹3.75 Crore in FY25 and Nil in FY24. The acquisition will allow Rainbow Childrens Medicare to augment the hospital's capacity by approximately 30 beds to support the expansion of gynaecology, obstetrics, and perinatal services.

Transaction Details

The aggregate consideration of ₹19.84 Cr is subject to adjustments as per the transaction documents. The investment will be financed through internal accruals. No governmental or regulatory approvals are required for this acquisition.

Capacity Expansion Impact

The acquisition adds 70 beds to Rainbow Childrens Medicare's existing capacity of 2,435 beds, which currently operates at 46.3% utilization. With this expansion, the company will operate 429 beds across four hospitals in Visakhapatnam, Vijayawada, Rajahmundry, and Nellore. This establishes a strong regional network spanning Andhra Pradesh, enabling the delivery of specialized pediatric, women, and neonatal care.

What the Numbers Show

The rapid revenue growth at Super Prime Medical Care LLP—from Nil in FY24 to ₹9.44 Crore in FY26—indicates a successful ramp-up phase post-incorporation in February 2023. Acquiring a majority stake in a profitable, growing asset allows Rainbow Childrens Medicare to bypass the initial setup risks associated with greenfield projects. The planned addition of 30 beds for women and perinatal services suggests a strategy to diversify the hospital's service mix beyond pediatrics, potentially improving overall bed utilization and cross-selling opportunities within the hub-and-spoke framework.

Rainbow Children's Medicare Limited has executed definitive transaction documents, including a Shareholders' Agreement, for the proposed development of a new children's and women's hospital at Malad, Mumbai. The project will be undertaken through its wholly owned subsidiary, Rainbow Women & Children's Hospital Private Limited (RWCHPL), and carries an estimated project cost of approximately ₹90 Crore. The transaction was disclosed to stock exchanges on July 29, 2026, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Strategic Capacity Addition in Western India

The proposed hospital at Malad, Mumbai is designed to add an incremental capacity of 100 beds, expanding Rainbow Children's Medicare's healthcare delivery network in Maharashtra. The company currently operates with an existing capacity of 2,435 beds and a capacity utilisation of 46.3%. The new facility is expected to be commissioned by Q1 FY27-28, subject to receipt of necessary approvals and completion of construction and development activities. The project will be financed entirely through internal accruals, with Rainbow Children's Medicare contributing approximately ₹68,40,00,000 of the total estimated project cost.

The following table summarises the key parameters of the proposed capacity addition:

Induction of Fountainhead TCHM Healthcare LLP

As part of the transaction, Fountainhead TCHM Healthcare LLP (LLP) is proposed to be inducted as an equity investor in RWCHPL. The LLP is promoted by a group of doctors — Dr. Susan Veena Fernandes, Dr. Vinay Hanamesh Joshi, and Dr. Allan Mark Pereira. Pursuant to the transaction documents, the LLP is proposed to acquire a 24% equity stake in RWCHPL, with the consideration for the equity transfer set at ₹24,000. The transaction is expected to be completed on or before August 31, 2026.

Upon completion, RWCHPL will cease to be a wholly owned subsidiary of Rainbow Children's Medicare and will continue as a subsidiary, with the following post-transaction shareholding structure:

Rainbow Children's Medicare will retain 76% of the equity share capital of RWCHPL and will continue to exercise control over the subsidiary. The buyer does not belong to the promoter, promoter group, or group companies of Rainbow Children's Medicare, and the proposed investment is to be made on an arm's length basis.

RWCHPL: Target Entity Background

Rainbow Women & Children's Hospital Private Limited was incorporated on December 13, 2010, and is engaged in managing and running hospitals, dispensaries, maternity homes, health centres, clinics, and diagnostic centres for providing medical services, surgery, and other allied services. The entity operates in India and is classified under the Healthcare Services industry. Its authorised capital stands at ₹50,00,000 and paid-up capital at ₹1,00,000. The turnover history of RWCHPL for the past three financial years is as follows:

Expanding the Maharashtra Healthcare Network

The 100-bed brownfield hospital in Malad, Mumbai complements a previously announced 150-bed regional hub in Pune, which is expected to commence operations in FY29. Together, these two facilities are intended to establish a hub-and-spoke network across Maharashtra, expanding Rainbow Children's Medicare's presence in Western India. The company's existing footprint spans multiple cities including Bengaluru, Chennai, Delhi, Guwahati, Hyderabad, Rajahmundry, Vijayawada, Visakhapatnam, and Warangal. The Malad project is aimed at enhancing the company's ability to deliver specialised paediatric, women's, and neonatal care across Maharashtra.